Skip to content
Home/Companies/HealthTech/Bodyport
Bodyport

Bodyport

HealthTech·US·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Bodyport?

Bodyport is currently owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage), since 2020.

Hand-verified · updated 2026-07-07

Boehringer Ingelheim Venture Fund
Investor
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund · 2010 · Evergreen

Key facts

HQUnited States
SectorHealthTech
StatusActive
Websitewww.bodyport.com

More from Boehringer Ingelheim Venture Fund

Other portfolio companies in the same fund.

ProTgen
Active
BiotechUS· 2024
Refoxy Pharmaceuticals
Refoxy Pharmaceuticals
Active
BiotechGermany· 2024
SwitchKine
Active
BiotechSwitzerland· 2024
Synthetica Pioneering
Active
BiotechChina· 2024
Aurobac Therapeutics
Aurobac Therapeutics
Active
BiotechFrance· 2023
Glox Therapeutics
Glox Therapeutics
Active
BiotechUK· 2023

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Bodyport

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Bodyport?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Bodyport.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue